1. Home
  2. EXPE vs KVUE Comparison

EXPE vs KVUE Comparison

Compare EXPE & KVUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Expedia Group Inc.

EXPE

Expedia Group Inc.

HOLD

Current Price

$303.14

Market Cap

39.5B

ML Signal

HOLD

Logo Kenvue Inc.

KVUE

Kenvue Inc.

HOLD

Current Price

$18.95

Market Cap

36.9B

ML Signal

HOLD

Company Overview

Basic Information
Metric
EXPE
KVUE
Founded
1996
2022
Country
United States
United States
Employees
N/A
N/A
Industry
Transportation Services
Specialty Chemicals
Sector
Consumer Discretionary
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
39.5B
36.9B
IPO Year
2005
2023

Fundamental Metrics

Financial Performance
Metric
EXPE
KVUE
Price
$303.14
$18.95
Analyst Decision
Buy
Buy
Analyst Count
29
11
Target Price
$275.89
$19.45
AVG Volume (30 Days)
1.4M
18.4M
Earning Date
05-07-2026
05-07-2026
Dividend Yield
0.77%
4.82%
EPS Growth
9.61
40.74
EPS
7.05
0.48
Revenue
$14,733,000,000.00
$15,124,000,000.00
Revenue This Year
$10.35
$4.85
Revenue Next Year
$6.93
$2.63
P/E Ratio
$43.69
$39.84
Revenue Growth
7.61
N/A
52 Week Low
$185.34
$14.02
52 Week High
$342.00
$20.69

Technical Indicators

Market Signals
Indicator
EXPE
KVUE
Relative Strength Index (RSI) 46.54 48.31
Support Level $271.13 $18.67
Resistance Level $336.66 $19.15
Average True Range (ATR) 11.77 0.31
MACD -4.97 -0.03
Stochastic Oscillator 6.63 33.53

Price Performance

Historical Comparison
EXPE
KVUE

About EXPE Expedia Group Inc.

Expedia is the world's second-largest online travel agency by bookings, offering services for lodging (80% of 2025 sales), air tickets (3%), rental cars, cruises, in-destination, and other (9%), and advertising revenue (8%). Expedia operates a number of branded travel booking sites, but its three core online travel agency brands are Expedia, Hotels.com, and alternative accommodations brand Vrbo. It also has a metasearch brand, Trivago. Transaction fees for online bookings account for the bulk of sales and profits.

About KVUE Kenvue Inc.

Kenvue is the world's largest pure-play consumer health company by sales, generating over $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of categories within consumer health, such as cough, cold, and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio has some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Kenvue announced in November 2025 that it signed a deal to be fully acquired by Kimberly-Clark, with the deal expected to close during the second half of 2026.

Share on Social Networks: